Income Statement (TTM)
Onconova Therapeutics, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Change (%) | 13.24 | 1.73 | 0.43 | -3.81 | -0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.44 | 1,178.85 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Change (%) | 13.24 | 1.73 | 0.43 | -3.81 | -0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.44 | 1,178.85 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 9 | 9 | 10 | 10 | 11 | 12 | 12 | 11 |
| Change (%) | -0.85 | 4.92 | 2.93 | 1.52 | 3.24 | -0.33 | -7.57 | -2.06 | -0.67 | -0.86 | 0.86 | 6.88 | 0.74 | 13.67 | -2.26 | 7.86 | 12.77 | -4.90 | -2.45 | |
| % of Revenue | 4,116.18 | 3,604.33 | 3,717.45 | 3,810.17 | 4,021.59 | 4,170.35 | 4,156.64 | 3,842.04 | 3,762.83 | 3,737.61 | 3,705.31 | 3,737.17 | 3,994.25 | 4,023.89 | 4,573.89 | 4,470.35 | 4,821.68 | 5,437.61 | 5,148.46 | 392.73 |
| R&D | 16 | 17 | 15 | 13 | 10 | 7 | 7 | 8 | 9 | 11 | 13 | 14 | 13 | 11 | 9 | 11 | 13 | 13 | 13 | 12 |
| Change (%) | 4.76 | -8.48 | -19.07 | -19.42 | -27.65 | 0.89 | 2.53 | 24.24 | 21.63 | 18.22 | 3.10 | -8.15 | -10.49 | -18.97 | 16.28 | 24.63 | -4.29 | 4.62 | -12.45 | |
| % of Revenue | 7,906.86 | 7,315.15 | 6,580.85 | 5,303.39 | 4,443.17 | 3,228.76 | 3,257.52 | 3,339.82 | 4,149.56 | 5,046.90 | 5,966.37 | 6,151.33 | 5,650.00 | 5,057.52 | 4,098.23 | 4,765.49 | 5,939.38 | 5,684.51 | 5,921.15 | 405.37 |
| OpEx | 25 | 25 | 24 | 22 | 19 | 17 | 17 | 16 | 18 | 20 | 22 | 22 | 22 | 21 | 20 | 21 | 24 | 25 | 25 | 23 |
| Change (%) | 2.84 | -4.06 | -11.13 | -10.66 | -12.97 | 0.20 | -3.13 | 10.17 | 11.02 | 10.10 | 2.24 | -2.47 | -5.84 | -4.51 | 6.50 | 16.51 | 3.36 | -0.03 | -7.80 | |
| % of Revenue | 12,023.04 | 10,919.48 | 10,298.30 | 9,113.56 | 8,464.76 | 7,399.12 | 7,414.16 | 7,181.86 | 7,912.39 | 8,784.51 | 9,671.68 | 9,888.50 | 9,644.25 | 9,081.42 | 8,672.12 | 9,235.84 | 10,761.06 | 11,122.12 | 11,069.60 | 798.11 |
| Operating Income | -24 | -25 | -24 | -21 | -19 | -16 | -17 | -16 | -18 | -20 | -22 | -22 | -22 | -20 | -19 | -21 | -24 | -25 | -25 | -20 |
| Change (%) | 2.75 | -4.11 | -11.24 | -10.74 | -13.12 | 0.21 | -3.18 | 10.32 | 11.16 | 10.22 | 2.27 | -2.50 | -5.90 | -4.56 | 6.58 | 16.69 | 3.39 | -0.04 | -18.61 | |
| % of Revenue | -11,923.04 | -10,819.48 | -10,198.30 | -9,013.56 | -8,364.76 | -7,299.12 | -7,314.16 | -7,081.86 | -7,812.39 | -8,684.51 | -9,571.68 | -9,788.50 | -9,544.25 | -8,981.42 | -8,572.12 | -9,135.84 | -10,661.06 | -11,022.12 | -10,969.60 | -698.11 |
| Interest Expense | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| Net Income | -24 | -25 | -25 | -22 | -19 | -16 | -16 | -15 | -17 | -19 | -21 | -21 | -20 | -19 | -18 | -137 | -141 | -167 | -140 | -18 |
| Change (%) | 2.79 | -1.50 | -12.77 | -12.90 | -14.15 | -3.67 | -1.33 | 12.66 | 9.57 | 8.72 | 1.10 | -3.16 | -6.12 | -4.18 | 654.84 | 2.73 | 18.28 | -15.90 | -87.27 | |
| % of Revenue | -11,997.55 | -10,890.48 | -10,544.68 | -9,159.32 | -8,294.27 | -7,151.77 | -6,889.38 | -6,797.79 | -7,658.41 | -8,391.15 | -9,122.57 | -9,222.57 | -8,930.97 | -8,384.07 | -8,033.63 | -60,641.15 | -62,294.25 | -73,682.74 | -61,696.04 | -613.92 |
Source: Capital IQ
